Treatment completion for latent tuberculosis infection: a retrospective cohort study comparing 9 months of isoniazid, 4 months of rifampin and 3 months of isoniazid and rifapentine

BACKGROUND: The U.S. Centers for Disease Control and Prevention (CDC) recommended a new regimen for treatment of latent tuberculosis (three months of weekly isoniazid and rifapentine) in late 2011. While completion rates of this regimen were reported to be higher than nine months of isoniazid, littl...

Descripción completa

Detalles Bibliográficos
Autores principales: McClintock, Adelaide H., Eastment, McKenna, McKinney, Christy M., Pitney, Caroline L., Narita, Masahiro, Park, David R., Dhanireddy, Shireesha, Molnar, Alexandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5310079/
https://www.ncbi.nlm.nih.gov/pubmed/28196479
http://dx.doi.org/10.1186/s12879-017-2245-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5310079/
https://www.ncbi.nlm.nih.gov/pubmed/28196479
http://dx.doi.org/10.1186/s12879-017-2245-8

Ejemplares similares